NEW YORK (GenomeWeb) – Precipio announced after the close of the market on Monday the completion of its public offering of securities that raised $2.7 million in gross proceeds.

The company completed its direct offering of 2,748 units, each unit comprising one share of Series C preferred stock, convertible at $1.40 per share, and warrants to purchase up to 1,962.857 shares of common stock at an exercise price of $1.63 per share.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.